Elucidating the role of interleukin 1 and prostaglandin E2 in upper airway mucosal wound healing

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 4, 2007, Pages 365-374

  Sandulache, Vlad C ^a,b,d   Chafin, J Brett ^a,b   Li Korotky, Ha Sheng ^a,b   Otteson, Todd D ^a,b   Dohar, Joseph E ^a,b,c,d   Hebda, Patricia A ^a,b,c,d  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON DIOXIDE LASER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; LARYNX INJURY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; SUBGLOTTIC STENOSIS; UPPER RESPIRATORY TRACT; UPREGULATION; WOUND HEALING;

ANIMALS; CARBON DIOXIDE; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOTTIS; INTERLEUKIN-1BETA; LASER SURGERY; MUCOUS MEMBRANE; POLYMERASE CHAIN REACTION; RABBITS; RNA, MESSENGER; WOUND HEALING;

EID: 34247367947     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.4.365     Document Type: Article

References (33)

1. Whitehead E, Salam MA. Use of the carbon dioxide laser with the Montgomery t-tube in the management of extensive subglottic stenosis. J Laryngol Otol. 1992;106:829-831.
2. Naiman AN, Ayari S, Froehlich P. Controlled risk of stenosis after surgical excision of laryngeal hemangioma. Arch Otolaryngol Head Neck Surg. 2003;129:1291-1295.
3. Cotton RT, Tewfik TL. Laryngeal stenosis following carbon dioxide laser in subglottic hemangioma: report of three cases. Ann Otol Rhinol Laryngol. 1985;94:494-497.
4. Wang Z, Volk MS, Shapshay SM. Endoscopic laryngotracheoplasty and graft soldering with the carbon dioxide laser: an animal study. Ann Otol Rhinol Laryngol. 1997;106:989-994.
5. Boxman I, Lowik C, Aarden L, Ponec M. Modulation of IL-6 production and IL-1 activity by keratinocyte-fibroblast interaction. J Invest Dermatol. 1993;101:316-324.
6. 2/collagenase production by human dermal fibroblasts and synovial cells. Immunobiology. 1990;180:316-327.
7. Bullard KM, Longaker MT, Lorenz HP. Fetal wound healing: current biology. World J Surg. 2003;27:54-61.
8. Liechty KW, Crombleholme TM, Cass DL, Martin B, Adzick NS. Diminished interleukin-8 production in the fetal wound healing response. J Surg Res. 1998;77:80-84.
9. Liechty KW, Adzick NS, Crombleholme TM. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine. 2000;12:671-676.
10. Liechty KW, Kim HB, Adzick NS, Crombleholme TM. Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg. 2000;35:866-872.
11. 4 receptor subtypes. J Leukoc Biol. 2003;73:756-763.
12. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79:1193-1226.
13. Abramovitz M, Adam M, Boie Y, et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta. 2000;1483:285-293.
14. 4 in the nuclear envelope. J Biol Chem. 1999;274:15719-15724.
15. 4 receptor sequestration. Mol Pharmacol. 2000;58:1279-1286.
16. Moore BB, Coffey MJ, Christensen P, et al. GM-CSF regulates bleomycininduced pulmonary fibrosis via a prostaglandin-dependent mechanism. J Immunol. 2000;165:4032-4039.
17. 2 synthesis by lung fibroblasts isolated from rats with bleomycin-induced lung fibrosis. Int J Exp Pathol. 1999;80:41-49.
18. Petkova DK, Clelland CA, Ronan JE, Lewis S, Knox AJ. Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis. Histopathology. 2003;43:381-386.
19. 2. Trends Immunol. 2004;25:40-46.
20. 2 and to express cyclooxygenase-2. J Clin Invest. 1995;95:1861-1868.
21. 2 syntase-1 expression in human synovial fibroblasts by interfering with Egr-1. J Biol Chem. 2004;279:22057-22065.
22. 2 synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A. 1999;96:7220-7225.
23. Tong M, Tai HH. 15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells. Arch Biochem Biophys. 2005;435:50-55.
24. Yan M, Rerko RM, Platzer P, et al. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers. Proc Natl Acad Sci U S A. 2004;101:17468-17473.
25. 4 receptor messenger RNA in fetal rabbit skin wound. Arch Otolaryngol Head Neck Surg. 2000;126:1337-1343.
26. Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol. 2004;68:1089-1100.
27. Gomez PF, Pillinger MH, Attur M, et al. Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-κB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts. J Immunol. 2005;175:6924-6930.
28. 2 receptors, and cyclic AMP-protein kinase A signaling. Mol Pharmacol. 2004;66:337-346.
29. 2 attenuates hyperoxia-induced injury in cultured rabbit tracheal epithelial cells. Pediatr Res. 1992;32:87-91.
30. Branski RC, Sandulache VC, Dohar JE, Hebda PA. Mucosal wound healing in a rabbit model of subglottic stenosis: biochemical analysis of secretions. Arch Otolaryngol Head Neck Surg. 2005;131:153-157.
31. Singer AJ, Clark RA. Cutaneous wound healing.NEngl J Med. 1999;341:738-746.
32. Wilgus TA, Bergdall VK, Tober KL, et al. The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing. Am J Pathol. 2004;165:753-761.
33. Backlund MG, Mann JR, Holla VR, et al. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem. 2005;280:3217-3223.